p53Arg72 homozygosity and its increased incidence in left-sided sporadic colorectal adenocarcinomas, in a Greek-Caucasian population

Anticancer Research

Volumn 28, Issue 2 A, 2008, Pages 1039-1043

  Dakouras, Anastasios ^a,e   Nikiteas, Nikolaos ^c   Papadakis, Emmanuel ^b   Perakis, Michael ^b   Valis, Dimitrios ^b   Rallis, George ^a   Tzanakis, Nikolaos ^a   Peros, George ^a   Tsigkris, Christos ^c   Kittas, Christos ^a   Karakitsos, Petros ^d  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Medicanalysis Molecular Biology and Microbiology Applications   (Greece)

^c LAIKO GENERAL HOSPITAL   (Greece)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^e NONE   (Greece)

Author keywords

Arg72Pro; Left colon cancer; p53 codon 72 polymorphism; Sporadic colorectal adenocarcinoma

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ALLELE; ARTICLE; CANCER GENETICS; CANCER INCIDENCE; CHI SQUARE TEST; CODON; COLON CANCER; COLORECTAL CARCINOMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA DETERMINATION; ETHNICITY; FEMALE; GENETIC POLYMORPHISM; GENOME; GREECE; HETEROZYGOTE DETECTION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; AGED; ARGININE; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GREECE; HOMOZYGOTE; HUMANS; INCIDENCE; MALE; POLYMORPHISM, GENETIC;

EID: 42549118494     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Vogelstein B and Kinzler KW: Tumour-suppressor genes. X-rays strike p53 again. Nature 370: 174-175, 1994.
2. Lozano G and Elledge S: p53 sends nucleotides to repair DNA. Nature 404: 24-25, 2000.
3. Donehower L: p53: guardian AND suppressor of longevity. Exp Gerontol 40: 7-9, 2004.
4. Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J and Crawford LV: Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 7: 961-963, 1987.
5. Thomas M, Kalita A, Labrecque S, Pim D, Banks L and Matlashewski G: Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19: 1092-1100, 1999.
6. Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, Yulug I, Merlano M, Numico G, Comino A, Attard M, Reelfs O, Gusterson B, Bell AK, Heath V, Tavassoli M, Farell PJ, Smith P, Lu X and Crook T: p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell 3: 387-402, 2003.
7. Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, Hiller L, Farell PJ, Smith P, Lu X and Crook T: Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene 23: 3328-3337, 2004.
8. Dumont P, Leu JI, Della Pietra AC, George DL and Murphy M: The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33: 357-365, 2003.
9. Pim D and Banks L: p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 108: 196-199, 2004.
10. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G and Banks L: Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393: 229-234, 1998.
11. Papadakis ED, Soulitzis N and Spandidos DA: Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes. Br J Cancer 87: 1013-1018, 2002.
12. Weston A, Caporaso NE, Perin LS, Sugimura H, Tamai S, Krontiris TG, Trump BF, Hoover RN and Harris CC: Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis. Environ Health Perspect 98: 61-67, 1992.
13. Langerod A, Buckholm IR, Bregard A, Lonning PE, Andersen TI, Rognum TO, Meling GI, Lothe RA and Borresen-Dale AL: The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas. Cancer Epidimiol Biomarkers Prev 11: 1684-1688, 2002.
14. Papadakis EN, Dokianakis DN and Spandidos DA: p53 codon 72 polymorphism as a risk factor in the development of breast cancer. Mol Cell Biol Res Commun 3: 389-392, 2000.
15. Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y and Xie Y: p53 codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer. Clin Cancer Res 11: 7328-7333, 2005.
16. Shen H, Solari A, Wang X, Zhang Z, Xu Y, Wang L, Hu X, Guo J and Wie Q: P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population. Oncol Rep 11: 1115-1120, 2004.
17. Zhou Y, Li N, Zhuang W, Liu GJ, Wu TX, Yao X, Du L, Wei ML and Wu XT: P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature. Int J Cancer 121: 1481-1486, 2007.
18. Zhu ZZ, Cong WM, Liu SF, Dong H, Zhu GS and Wu MC: Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population. World J Gastroenetrol 11: 289-292, 2005.
19. Weitz J, Koch M, Debus J, Hohler T, Galle PR and Buchler MW: Colorectal cancer. Lancet 365: 153-165, 2005.
20. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
21. Olschwang S, Laurent-Puig P, Vassal A, Salmon RJ and Thomas G: Characterisation of a frequent polymorphism in the coding sequence of the Tp53 in colonic cancer patients and a control population. Hum Genet 86: 369-370, 1991.
22. Sjalander A, Birgander R, Athlin L, Stenling R, Rutegard J, Beckman L and Beckman G: p53 germ line haplotypes associated with increased risk for colorectal cancer. Carcinogenesis 16: 1461-1464, 1995.
23. Sayhan N, Yazici H, Budak M, Bitisik O and Dalay N: P53 codon 72 genotypes in colon cancer. Association with human papillomavirus infection. Res Commun Mol Pathol Pharmacol 109: 25-34, 2001.
24. Gemignani F, Moreno V, Landi S, Moullan N, Chabrier A, Gutierrez-Enriquez S, Hall J, Guino E, Peinado MA, Capella G and Canzian F: A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. Oncogene 23: 1954-1956, 2004.
25. Lung FW, Lee TM, Shu BC and Chang FH: p53 codon 72 polymorphism and susceptibility malignancy of colorectal cancer in Taiwan. J Cancer Res Clin Oncol 130: 728-732, 2004.
26. Koushik A, Tranah GJ, Ma J, Stampfer MJ, Sesso HD, Fuchs CS, Giovannucci EL and Hunter DJ: p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Int J Cancer 119: 1863-1868, 2006.
27. Perez LO, Abba MC, Dulout FN and Golijow CD: Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J Gastroenetrol 12: 1426-1429, 2006.
28. Sjalander A, Birgander R, Saha N, Beckman L and Beckman G: p53 polymorphisms and haplotypes show distinct differences between major ethnic groups. Hum Hered 46: 41-48, 1996.
29. Siddique MM, Balram C, Fiszer-Maliszewska L, Aggarwal A, Tan A, Tan P, Soo KC and Sabapathy K: Evidence for selective expression of the p53 codon 72 polymorphs: implications in cancer development. Cancer Epidemiol Biomarkers Prev 14: 2245-2252, 2005.
30. Bowtell DD: Rapid isolation of eukaryotic DNA. Anal Biochem 162: 463-465, 1987.
31. Koushik A, Platt RW and Franco EL: p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev 13: 11-22, 2004.
32. Matakidou A, Eisen T and Houlston RS: TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 18: 377-385, 2003.
33. Beckman G, Birgander R, Själander A, Saha N, Holmberg PA, Kivelä A and Beckman L: Is p53 polymorphism maintained by natural selection? Hum Hered 44: 266-270, 1994.
34. Soulitzis N, Sourvinos G, Dokianakis DN and Spandidos DA: p53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett 179: 175-183, 2002.
35. Agorastos T, Lambropoulos AF, Constantinidis TC, Kotsis A and Bontis JN: p53 codon 72 polymorphism and risk of intraepithilial and invasive cervical neoplasia in Greek women. Eur J Cancer Prev 9: 113-118, 2000.
36. Williams C, Pontén F, Moberg C, Söderkvist P, Uhlén M, Pontén J, Sitbon G and Lundeberg J: A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am J Pathol 155: 1467-1471, 1999.
37. Breivik J, Lothe RA, Meling GI, Rognum TO, Børresen-Dale AL and Gaudernack G: Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer 74: 664-669, 1997.
38. Gervaz P, Bucher P and Morel P: Two colons-two cancers: paradigm shift and clinical implications. J Surg Oncol 88: 261-266, 2004.